Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017Makoto Kinoshita, Shizuya Yamashita, Koutaro Yokote et al.|Journal of Atherosclerosis and Thrombosis|2018Cited by 821
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal DiseaseCarmine Zoccali, Yūji Matsuzawa, Tohru Funahashi et al.|Journal of the American Society of Nephrology|2002Cited by 761
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 VersionTamio Teramoto, Koutaro Yokote, Junichi Sasaki et al.|Journal of Atherosclerosis and Thrombosis|2013Cited by 469
The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic SyndromeAnthony G. Comuzzie, Ahmed H. Kissebah, Tohru Funahashi et al.|The Journal of Clinical Endocrinology & Metabolism|2001Cited by 312
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022Tomonori Okamura, Hidekatsu Yanai, Kazuhisa Tsukamoto et al.|Journal of Atherosclerosis and Thrombosis|2023Cited by 269